19 Compelling Reasons That May Make Reckitt Benckiser plc A Buy

Royston Wild reveals why shares in Reckitt Benckiser plc (LON: RB) look set to stride higher.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I am explaining why I believe shares in Reckitt Benckiser (LSE: RB) (NASDAQOTH: RBGLY.US) are set to march higher on the back of its powerful portfolio of household brands.

Blockbuster brands to deliver bountiful gains

Shares in household goods giant Reckitt Benckiser have shot higher in recent weeks, leaping more than 11% since in just over a fortnight and boosted by bubbly third-quarter financial results. Net revenues, on a constant currencies basis, rose 6% in the January-September period to £7.54bn, the company said.

And in my opinion the firm can look forward to further excellent revenues growth, with its galloping emerging market exposure and portfolio of industry-leading ‘Powerbrands‘ leading the charge. In particular, I believe that the strength of these 19 self-monikered labels are key to the firm’s future expansion story.

Reckitt Benckiser’s stable of premier labels are sold in more than 200 countries and include the likes of dishwasher cleaner Finish, sore throat reliever Strepsils and condom brand Durex, all three of which are the most popular global brands in their fields. And Reckitt Benckiser’s successful roll-out of these labels in new markets, combined with novel innovations across a multitude of these brands, are helping to drive revenues higher.

Indeed, brand strength here is helping to drive the firm’s push into exciting emerging regions, and Reckitt Benckiser saw turnover in Latin America, Asia Pacific, Australasia and China rise 10% in January-September. These labels also helped to deliver 7% growth in otherwise-stagnant Western consumer markets during the period — the firm’s Mucinex chest congestion product and Lysol disinfectant line were mainly responsible for growth in North America during July-September, for example.

Many commentators believe that recent share price strength has worsened Reckitt Benckiser’s already bloated valuation and thus investment appeal. The business was recently dealing on a forward P/E multiple of 18.1, comfortably surpassing a corresponding readout of 15.3 for the complete household goods and home construction sector.

Still, I believe that the company is a great pick for those seeking the security of dependable and chunky earnings growth year after year — indeed, earnings per share have grown at a compound annual growth rate of 10.7% over the past five years. Reckitt Benckiser’s heavyweight Powerbrands have the ability to not only deliver strong revenues growth, but also maintain its encouraging margin story, a critical earnings safety net in the event of a fresh macroeconomic slowdown.  

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

> Royston does not own shares in Reckitt Benckiser.

More on Investing Articles

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

I’d put £20K in an ISA now to target a £1,900 monthly second income in future!

Christopher Ruane shares why he thinks a long-term approach to investing and careful selection of shares could help him build…

Read more »

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

The market is wrong about this FTSE 250 stock. I’m buying it in April

Stephen Wright thinks investors should look past a 49% decline in earnings per share and consider investing in a FTSE…

Read more »